MONTVALE, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its third quarter 2005 financial results on Tuesday, November 8, 2005, before the U.S. financial markets open. Management will provide a Company update and discuss the third quarter results during a conference call on Tuesday, November 8, 2005, at 11:00 a.m. ET. Tony Scullion, Executive Chairman, Jim Sulat, President and Chief Executive Officer, and Dr. David Lowe, Chief Scientific Officer, will host the conference call.
Investors and other interested parties may access the call as follows: Date: Tuesday, November 8, 2005 Time: 11:00 a.m. ET Telephone (U.S.): 866-578-5784 Telephone (international): 617-213-8056 Participant Passcode: 83417903 Webcast: http://www.memorypharma.com under the “Investors” section
An audio replay of the conference call will be available from 1:00 p.m. EDT on Tuesday, November 8, 2005, until Tuesday, November 15, 2005. To access the replay, please dial 888-286-8010 (U.S.) or 617-801-6888 (international) and enter pass code number 89813462. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression, vascular dementia, mild cognitive impairment, Parkinson’s disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;or Laura Perry, Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
